loadpatents
Patent applications and USPTO patent grants for Kaufman; Bella.The latest application filed is for "klotho protein and related compounds for the treatment and diagnosis of cancer".
Patent | Date |
---|---|
Klotho protein and related compounds for the treatment and diagnosis of cancer Grant 10,555,963 - Wolf , et al. Feb | 2020-02-11 |
Klotho protein and related compounds for the treatment and diagnosis of cancer Grant 9,987,326 - Koeffler , et al. June 5, 2 | 2018-06-05 |
Klotho Protein And Related Compounds For The Treatment And Diagnosis Of Cancer App 20120178699 - WOLF; Ido ;   et al. | 2012-07-12 |
Klotho Protein and Related Compounds for the Treatment and Diagnosis of Cancer App 20120172314 - Koeffler; H. Phillip ;   et al. | 2012-07-05 |
Methods And Kits For Determining Predisposition To Cancer App 20120014927 - Rubinek; Tamar ;   et al. | 2012-01-19 |
GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer App 20110046071 - Karasik; Avraham ;   et al. | 2011-02-24 |
Klotho Protein And Related Compounds For The Treatment And Diagnosis Of Cancer App 20100330062 - Koeffler; H. Phillip ;   et al. | 2010-12-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.